Both breast and ovarian cancer risk is influenced by a variety of factors, including age, family history, lifestyle, and more. Variations in two specific genes, BRCA1 and BRCA2, also influence the ...
The current testing rate for BRCA 1/2 mutations is currently 68% in HER2-negative early breast cancer, but eligible patients could receive better care if tested. The current rate of BRCA1/2 testing ...
Scientists have developed a new clinical pathway for testing for the cancer-causing faults in the BRCA gene that could ensure patients get the right treatment and boost the number of people who get ...
Not only do home genetic test kits, like 23andMe, provide information about your ancestry, but they can also give you some insights into your inherited health risks, particularly mutations on the BRCA ...
Carlette Burton knew she had a family history of cancer, but she never looked into her genetic risk for BRCA-related cancer until she found a concerning lump in her breast during a self check in ...
From left: Dr Allan Njau, Consultant Anatomic and Molecular Pathologist, Dr Affrin Shaffi, and Dr Njoki Njiraini during the AstraZeneca BRCA testing launch in Nairobi, November 28, 2025. [Ryan Kerubo, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results